166 related articles for article (PubMed ID: 4078364)
1. Effect of clofazimine: detailed studies of small intestine functions.
Bhasin DK; Kumar B; Broor SL; Kaur S; Malik AM; Mehra SK
Indian J Lepr; 1985; 57(2):364-72. PubMed ID: 4078364
[TBL] [Abstract][Full Text] [Related]
2. More about clofazimine--3 years experience and review of literature.
Kumar B; Kaur S; Kaur I; Gangowar DN
Indian J Lepr; 1987; 59(1):63-74. PubMed ID: 3611862
[TBL] [Abstract][Full Text] [Related]
3. [Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease].
Davy C; Riveau E; Bousquet JC; Curet P; Vayre P; Cortez A; Grellet J
J Radiol; 1986 Mar; 67(3):213-8. PubMed ID: 3528476
[TBL] [Abstract][Full Text] [Related]
4. Gastro-intestinal side effects of clofazimine.
Lal S; Garg BR; Hameedulla A
Lepr India; 1981 Apr; 53(2):285-8. PubMed ID: 7253579
[TBL] [Abstract][Full Text] [Related]
5. Clofazimine in lepra (ENL) reaction, one year clinical trial.
Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of effectiveness of clofazimine therapy. I. Monitoring of absorption of clofazimine from gastrointestinal tract.
Mathur A; Venkatesan K; Bharadwaj VP; Ramu G
Indian J Lepr; 1985; 57(1):146-8. PubMed ID: 3839813
[TBL] [Abstract][Full Text] [Related]
7. Effect of clofazimine on eye in multibacillary leprosy.
Kaur I; Ram J; Kumar B; Kaur S; Sharma VK
Indian J Lepr; 1990; 62(1):87-90. PubMed ID: 2358706
[TBL] [Abstract][Full Text] [Related]
8. Effect of one year clofazimine therapy on autonomic functions in lepromatous leprosy with lepra (ENL) reaction.
Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
Lepr India; 1983 Apr; 55(2):278-85. PubMed ID: 6688841
[TBL] [Abstract][Full Text] [Related]
9. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
10. Side effects of clofazimine therapy.
Ramu G; Iyer GG
Lepr India; 1976 Oct; 48(4 Suppl):722-31. PubMed ID: 1026810
[TBL] [Abstract][Full Text] [Related]
11. [Enteropathy caused by clofazimine].
Jost JL; Venencie PY; Cortez A; Orieux G; Debbasch L; Chomette G; Puissant A; Vayre P
J Chir (Paris); 1986 Jan; 123(1):7-9. PubMed ID: 3958073
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the small bowel in lepromatous leprosy.
Kumar N; Malhotra V; Singh R; Vij JC; Anand BS
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):148-51. PubMed ID: 6889576
[TBL] [Abstract][Full Text] [Related]
13. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Mendis S; Somasiri KG; Chularatna W
Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical toxicity studies with clofazimine (B663) in leprosy.
Hastings RC; Jacobson RR; Trautman JR
Int J Lepr Other Mycobact Dis; 1976; 44(3):287-93. PubMed ID: 824210
[TBL] [Abstract][Full Text] [Related]
15. Experiences with clofazimine therapy in leprosy.
Kundu SK; Hazra SK; Choudhury S; Ghosh S
Lepr India; 1976 Oct; 48(4 Suppl):695-702. PubMed ID: 1026806
[No Abstract] [Full Text] [Related]
16. [Enteropathy due to clofazimine treatment. A case report with an ultrastructural study].
De Micco C; Boutboul R; Devaux J; Charpin C; Toga M
Ann Pathol; 1982; 2(2):149-54. PubMed ID: 7104069
[TBL] [Abstract][Full Text] [Related]
17. Clofazimine-induced enteropathy in a patient of leprosy.
Singh H; Azad K; Kaur K
Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
[TBL] [Abstract][Full Text] [Related]
18. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
19. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
Chandorkar AG; Burte NP; Gade RK; Bulakh PM
Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
[TBL] [Abstract][Full Text] [Related]
20. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
